
mAbxience Launches AI Project with HP to Optimise Biologic Manufacturing
mAbxience, a Fresenius entity, has entered a strategic collaboration with HP Inc. to develop an artificial intelligence (AI) solution designed to optimise the manufacturing of monoclonal antibodies and biosimilars. The new system includes a digital twin of the biological process








